These results, together with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two support the idea of concentrating on ACKR3 as a unique strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-related disorders. Note: Benefits could vary about https://altonr736jos1.techionblog.com/profile